Novartis Investigative Site

Ansan, Gyeonggi-do 425-801

1 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis, Cardiovascular Disease, Type 2 Diabetes Mellitus

Studies at this site

• Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis — Recruiting now
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early